Works by Yueyin Pan

Results: 60

TCF19 expression and significance analysis in breast cancer: integrated bioinformatics analysis and histological validation.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02546-8

By:

Yu, Haiyang;
Wei, Jingjing;
Chen, Qinhao;
Pan, Yueyin;
Qian, Xiaojun;
Pan, Jing;
Sun, Yubei

Publication type:

Article

Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancer.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02094-0

By:

Li, Yan;
Xu, Chao;
Qian, Xiaojun;
Wang, Gang;
Han, Chaoqiang;
Hua, Hui;
Dong, Menghao;
Chen, Jian;
Yu, Haiyang;
Zhang, Rutong;
Feng, Xiaoxi;
Yang, Zhenye;
Pan, Yueyin

Publication type:

Article

Synergistic effects of combined treatment with simvastatin and exemestane on MCF-7 human breast cancer cells.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 1, p. 456, doi. 10.3892/mmr.2015.3406

By:

YUANYUAN SHEN;
YINGYING DU;
YING ZHANG;
YUEYIN PAN

Publication type:

Article

Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis.

Published in:

Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02026-5

By:

Dong, Menghao;
Chen, Jian;
Lu, Nannan;
Wang, Song;
Wei, Wenhui;
Wang, Ziming;
Wang, Jinnan;
Zhang, Jinguo;
Han, Xinghua;
Wang, Fufeng;
Ou, Qiuxiang;
Bao, Hua;
Ma, Xiaopeng;
Shan, Benjie;
Pan, Yueyin

Publication type:

Article

Energy restriction causes metaphase delay and chromosome mis-segregation in cancer cells.

Published in:

Cell Cycle, 2021, v. 20, n. 12, p. 1195, doi. 10.1080/15384101.2021.1930679

By:

Cheng, Aoxing;
Jiang, Ya;
Wang, Ting;
Yu, Fazhi;
Ishrat, Iqra;
Zhang, Dongming;
Ji, Xiaoyang;
Chen, Minhua;
Xiao, Weihua;
Li, Qing;
Zhang, Kaiguang;
Niu, Gang;
Shi, Jue;
Pan, Yueyin;
Yang, Zhenye;
Guo, Jing

Publication type:

Article

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02999-0

By:

Cao, Jun;
Teng, Yuee;
Li, Huiping;
Zhang, Lili;
Ouyang, Quchang;
Xie, Weimin;
Pan, Yueyin;
Song, Zhenchuan;
Ling, Xiaoling;
Wu, Xiaohong;
Xu, Jingwei;
Li, Li;
Ren, Liping;
Wang, Hong;
Zhou, Dongxian;
Luo, Jing;
Hu, Xichun

Publication type:

Article

On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.

Published in:

Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-021-01479-4

By:

Jiang, Tao;
Chen, Jianhua;
Xu, Xingxiang;
Cheng, Ying;
Chen, Gongyan;
Pan, Yueyin;
Fang, Yong;
Wang, Qiming;
Huang, Yunchao;
Yao, Wenxiu;
Wang, Rui;
Li, Xingya;
Zhang, Wei;
Zhang, Yanjun;
Hu, Sheng;
Guo, Renhua;
Shi, Jianhua;
Wang, Zhiwu;
Cao, Peiguo;
Wang, Donglin

Publication type:

Article

Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy.

Published in:

China Oncology, 2022, v. 32, n. 1, p. 90, doi. 10.19401/j.cnki.1007-3639.2022.01.012

By:

LU Renquan;
LIU Guangyu;
YANG Wentao;
GUO Lin;
GUAN Ming;
SHAO Zhimin;
XU Dazhi;
NI Ming;
TANG Feng;
WANG Chaofu;
LOU Jiatao;
SUN Fenyong;
XING Jinliang;
PAN Yueyin

Publication type:

Article

Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 13, n. 6, p. 3067, doi. 10.3892/etm.2017.4356

By:

YITAO WAN;
YUAN YUAN;
YUEYIN PAN;
YING ZHANG

Publication type:

Article

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas.

Published in:

Cancer Medicine, 2021, v. 10, n. 5, p. 1848, doi. 10.1002/cam4.3748

By:

Chen, Jian;
Li, Yuntian;
Han, Xinghua;
Pan, Yueyin;
Qian, Xiaojun

Publication type:

Article

Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29018-9

By:

Wu, Mingming;
Zhang, Xiao;
Zhang, Weijie;
Chiou, Yi Shiou;
Qian, Wenchang;
Liu, Xiangtian;
Zhang, Min;
Yan, Hong;
Li, Shilan;
Li, Tao;
Han, Xinghua;
Qian, Pengxu;
Liu, Suling;
Pan, Yueyin;
Lobie, Peter E.;
Zhu, Tao

Publication type:

Article

MDM2 SNP309 Polymorphism and Colorectal Cancer Risk: Appraisal of a Recent Meta-Analysis.

Published in:

DNA & Cell Biology, 2012, v. 31, n. 3, p. 269, doi. 10.1089/dna.2011.1474

By:

Tian, Jing;
Pan, Feng;
Pan, Yueyin;
Zhang, Ying

Publication type:

Article

Lack of Association Between CDH1 C−160A Genetic Polymorphism and Gastric Cancer Risk Among Asian Population.

Published in:

DNA & Cell Biology, 2012, v. 31, n. 3, p. 274, doi. 10.1089/dna.2011.1495

By:

Pan, Feng;
Tian, Jing;
Zhang, Ying;
Pan, Yueyin

Publication type:

Article

Three Genetic Polymorphisms of Homocysteine-Metabolizing Enzymes and Risk of Coronary Heart Disease: Appraisal of a Recent Meta-Analysis.

Published in:

2012

By:

Pan, Feng;
Tian, Jing;
Zhang, Ying;
Pan, Yueyin

Publication type:

Letter

Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer.

Published in:

Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 18, p. 8890, doi. 10.1111/jcmm.16850

By:

Wu, Shusheng;
Cao, Lulu;
Ke, Lihong;
Yan, Ying;
Luo, Huiqin;
Hu, Xiaoxiu;
Niu, Jiayu;
Li, Huimin;
Xu, Huijun;
Chen, Wenju;
Pan, Yueyin;
He, Yifu

Publication type:

Article

Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer.

Published in:

Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0657-1

By:

Huang, Dabing;
Wang, Yong;
He, Yifu;
Wang, Gang;
Wang, Wei;
Han, Xinghua;
Sun, Yubei;
Lin, Lin;
Shan, Benjie;
Shen, Guodong;
Cheng, Min;
Bian, Geng;
Fang, Xiang;
Hu, Shilian;
Pan, Yueyin

Publication type:

Article

MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells.

Published in:

Cancer Cell International, 2017, v. 17, p. 1, doi. 10.1186/s12935-017-0389-7

By:

Dabing Huang;
Geng Bian;
Yueyin Pan;
Xinghua Han;
Yubei Sun;
Yong Wang;
Guodong Shen;
Min Cheng;
Xiang Fang;
Shilian Hu

Publication type:

Article

artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients.

Published in:

Briefings in Bioinformatics, 2021, v. 22, n. 6, p. 1, doi. 10.1093/bib/bbab190

By:

Chen, Jian;
Qian, Xiaojun;
He, Yifu;
Han, Xinghua;
Pan, Yueyin

Publication type:

Article

A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31704-7

By:

Wang, Biyun;
Sun, Tao;
Zhao, Yannan;
Wang, Shusen;
Zhang, Jian;
Wang, Zhonghua;
Teng, Yue-E;
Cai, Li;
Yan, Min;
Wang, Xiaojia;
Jiang, Zefei;
Pan, Yueyin;
Luo, Jianfeng;
Shao, Zhimin;
Wu, Jiong;
Guo, Xiaomao;
Hu, Xichun

Publication type:

Article

Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.

Published in:

Medical Science Monitor, 2017, v. 23, p. 412, doi. 10.12659/MSM.902645

By:

Xinghua Han;
Nannan Lu;
Yueyin Pan;
Jianming Xu

Publication type:

Article

Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.

Published in:

Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 9, p. 1397, doi. 10.1007/s00432-011-1009-x

By:

Pan, Feng;
Tian, Jing;
Zhang, Xuchao;
Zhang, Ying;
Pan, Yueyin

Publication type:

Article

Pan-cancer and single-cell analysis reveals FAM83D expression as a cancer prognostic biomarker.

Published in:

Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.1009325

By:

Haiyang Yu;
Qinhao Chen;
Ziming Wang;
Xiaojun Qian;
Yueyin Pan

Publication type:

Article

Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung Adenocarcinoma.

Published in:

Oxidative Medicine & Cellular Longevity, 2022, p. 1, doi. 10.1155/2022/3583985

By:

Zhang, Jinguo;
Han, Xinghua;
Lin, Lin;
Chen, Jian;
Wang, Feng;
Ding, Qi;
Hao, Li;
Wang, Lingyu;
Wei, Jie;
Wang, Yong;
Pan, Yueyin

Publication type:

Article

Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI.

Published in:

BMC Medical Imaging, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12880-021-00688-z

By:

Lu, Nannan;
Dong, Jie;
Fang, Xin;
Wang, Lufang;
Jia, Wei;
Zhou, Qiong;
Wang, Lingyu;
Wei, Jie;
Pan, Yueyin;
Han, Xinghua

Publication type:

Article

Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1–3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.

Published in:

Investigational New Drugs, 2023, v. 41, n. 6, p. 808, doi. 10.1007/s10637-023-01396-x

By:

Deng, Ting;
Zhang, Le;
Shi, Yehui;
Bai, Guiying;
Pan, Yueyin;
Shen, Aizong;
Han, Xinghua;
Yang, Zhaoyi;
Chen, Mingxia;
Zhou, Hui;
Luo, Yang;
Zheng, Shirui;
Ba, Yi

Publication type:

Article

Novel key genes in triple‐negative breast cancer identified by weighted gene co‐expression network analysis.

Published in:

Journal of Cellular Biochemistry, 2019, v. 120, n. 10, p. 16900, doi. 10.1002/jcb.28948

By:

Chen, Jian;
Qian, Xiaojun;
He, Yifu;
Han, Xinghua;
Pan, Yueyin

Publication type:

Article

Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03715-4

By:

Ren, Shengxiang;
Xiong, Anwen;
Yu, Jia;
Wang, Xicheng;
Han, Baohui;
Pan, Yueyin;
Zhao, Jun;
Cheng, Yufeng;
Hu, Sheng;
Liu, Tianshu;
Li, Yalun;
Cheng, Ying;
Feng, Jifeng;
Yi, Shanyong;
Gu, Shanzhi;
Gao, Shegan;
Luo, Yongzhong;
Liu, Ying;
Liu, Caigang;
Duan, Huijie

Publication type:

Article

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment.

Published in:

Open Medicine, 2020, v. 15, n. 1, p. 659, doi. 10.1515/med-2020-0201

By:

Qiong Zhou;
Jie Dong;
Xiaodong Jiang;
Yueyin Pan;
Xinghua Han

Publication type:

Article

Relationship between Helicobacter pylori infection and vomiting induced by gastrointestinal cancer chemotherapy.

Published in:

Internal Medicine Journal, 2017, v. 47, n. 7, p. 792, doi. 10.1111/imj.13428

By:

Yao, Yiwei;
Ji, Chushu;
He, Yifu;
Pan, Yueyin

Publication type:

Article

Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study.

Published in:

Cancer Medicine, 2024, v. 13, n. 15, p. 1, doi. 10.1002/cam4.7408

By:

Shao, Zhimin;
Tong, Zhongsheng;
Liu, Qiang;
Li, Wei;
Cai, Li;
Shen, Kunwei;
Li, Huiping;
Wang, Chuan;
Yang, Jin;
Song, Zhenchuan;
Wang, Shui;
Luo, Ting;
Zhao, Wenhe;
Wang, Haibo;
Pan, Yueyin;
Nie, Jianyun;
Zeng, Xiaohua;
Bai, Yanqing;
Chiang, Wendy;
Guarnaccia, Valeria

Publication type:

Article

Expression Patterns of Ezrin and AJAP1 and Clinical Significance in Breast Cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.831507

By:

Xu, Cong;
Wang, Feng;
Hao, Li;
Liu, Jing;
Shan, Benjie;
Lv, Shuhua;
Han, Xinghua;
Pan, Yueyin;
Niu, Yun

Publication type:

Article

Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.

Published in:

Thyroid, 2020, v. 30, n. 9, p. 1245, doi. 10.1089/thy.2019.0453

By:

Chen, Jiaying;
Ji, Qinghai;
Bai, Chunmei;
Zheng, Xiangqian;
Zhang, Yuan;
Shi, Feng;
Li, Xiaojiang;
Tang, Pingzhang;
Xu, Zhengang;
Huang, Rui;
Huang, Tao;
Pan, Yueyin;
Fan, Songhua;
Zhou, Jinghong;
Su, Weiguo

Publication type:

Article

Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma.

Published in:

Theranostics, 2021, v. 11, n. 1, p. 257, doi. 10.7150/thno.51243

By:

Tao Jiang;
Liyan Jiang;
Xiaorong Dong;
Kangsheng Gu;
Yueyin Pan;
Qin Shi;
Guojun Zhang;
Huijuan Wang;
Xiaochun Zhang;
Nong Yang;
Yuping Li;
Jianping Xiong;
Tienan Yi;
Min Peng;
Yong Song;
Yun Fan;
Jiuwei Cui;
Gongyan Chen;
Wei Tan;
Aimin Zang

Publication type:

Article

FOXA1‐induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF‐β signaling pathway.

Published in:

Thoracic Cancer, 2023, v. 14, n. 21, p. 2026, doi. 10.1111/1759-7714.14986

By:

Wei, Jingjing;
Yu, Haiyang;
Liu, Tan;
Wang, Ziming;
Lang, Chuandong;
Pan, Yueyin

Publication type:

Article

Study of efficacy and safety of pulsatile administration of high-dose gefitinib or erlotinib for advanced non-small cell lung cancer patients with secondary drug resistance: A single center, single arm, phase II clinical trial.

Published in:

Thoracic Cancer, 2016, v. 7, n. 6, p. 663, doi. 10.1111/1759-7714.12384

By:

Zhu, Yanzhe;
Du, Yingying;
Liu, Hu;
Ma, Tai;
Shen, Yuanyuan;
Pan, Yueyin

Publication type:

Article

Prognostic role of LSD1 in various cancers: evidence from a meta-analysis.

Published in:

OncoTargets & Therapy, 2015, v. 8, p. 2565, doi. 10.2147/OTT.S89597

By:

Jin Wu;
Lixia Hu;
Yingying Du;
Fanliang Kong;
Yueyin Pan

Publication type:

Article

Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study.

Published in:

Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241260985

By:

Qin, Shukui;
Wang, Yusheng;
Yao, Jun;
Liu, Yanyan;
Yi, Tienan;
Pan, Yueyin;
Chen, Zhendong;
Zhang, Xizhi;
Lu, Jin;
Yu, Junyan;
Zhang, Yanjun;
Cheng, Peng;
Mao, Yong;
Zhang, Jian;
Fang, Meiyu;
Zhang, Yanming;
Lv, Jing;
Li, Runzi;
Dou, Ning;
Tang, Qian

Publication type:

Article

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.

Published in:

Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241264730

By:

Yu, Yongfeng;
Dong, Wen;
Shi, Yanxia;
Wu, Rong;
Yu, Qitao;
Ye, Feng;
Zhou, Chengzhi;
Dong, Xiaorong;
Li, Xingya;
Li, Yongsheng;
Li, Zhen;
Wu, Lin;
Pan, Yueyin;
Shen, Hong;
Wu, Dehua;
Xu, Zhongyuan;
Wu, Jinsheng;
Xu, Nong;
Qin, Yanru;
Zang, Aimin

Publication type:

Article

Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018).

Published in:

2020

By:

Xu, Binghe;
Hu, Xichun;
Feng, Jifeng;
Geng, Cuizhi;
Jin, Feng;
Li, Hongyuan;
Li, Man;
Li, Qing;
Liao, Ning;
Liu, Donggeng;
Liu, Jian;
Liu, Qiang;
Lu, Jinsong;
Liu, Zhenzhen;
Ma, Fei;
Ouyang, Quchang;
Pan, Yueyin;
Shen, Kunwei;
Sun, Tao;
Teng, Yuee

Publication type:

journal article

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.

Published in:

2021

By:

Dong, Jie;
Sun, Qingqing;
Pan, Yueyin;
Lu, Nannan;
Han, Xinghua;
Zhou, Qiong

Publication type:

journal article

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Published in:

2025

By:

Wan, Mengting;
Pan, Shuaikang;
Shan, Benjie;
Diao, Haizhou;
Jin, Hongwei;
Wang, Ziqi;
Wang, Wei;
Han, Shuya;
Liu, Wan;
He, Jiaying;
Zheng, Zihan;
Pan, Yueyin;
Han, Xinghua;
Zhang, Jinguo

Publication type:

Literature Review

A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.

Published in:

Gastric Cancer, 2018, v. 21, n. 5, p. 782, doi. 10.1007/s10120-018-0809-y

By:

Lu, Zhihao;
Zhang, Xiaotian;
Liu, Wei;
Liu, Tianshu;
Hu, Bing;
Li, Wei;
Fan, Qingxia;
Xu, Jianming;
Xu, Nong;
Bai, Yuxian;
Pan, Yueyin;
Xu, Qing;
Bai, Wei;
Xia, Li;
Gao, Yong;
Wang, Wenling;
Shu, Yongqian;
Shen, Lin

Publication type:

Article

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 3, doi. 10.1002/cac2.12225

By:

Zhang, Jie;
Pan, Yueyin;
Shi, Qin;
Zhang, Guojun;
Jiang, Liyan;
Dong, Xiaorong;
Gu, Kangsheng;
Wang, Huijuan;
Zhang, Xiaochun;
Yang, Nong;
Li, Yuping;
Xiong, Jianping;
Yi, Tienan;
Peng, Min;
Song, Yong;
Fan, Yun;
Cui, Jiuwei;
Chen, Gongyan;
Tan, Wei;
Zang, Aimin

Publication type:

Article

MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer.

Published in:

Oncology Letters, 2021, v. 21, n. 5, p. N.PAG, doi. 10.3892/ol.2021.12628

By:

Liu, Tan;
Wang, Ziming;
Dong, Menghao;
Wei, Jingjing;
Pan, Yueyin

Publication type:

Article

An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer.

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.704655

By:

Fu, Changfang;
Liu, Yu;
Han, Xinghua;
Pan, Yueyin;
Wang, Hong-qiang;
Wang, Hongzhi;
Dai, Haiming;
Yang, Wulin

Publication type:

Article

Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.

Published in:

Cancers, 2023, v. 15, n. 17, p. 4360, doi. 10.3390/cancers15174360

By:

Wu, Xinyu;
Jin, Nan;
Gao, Hongfei;
Yan, Min;
Chen, Qianjun;
Sun, Tao;
Hao, Chunfang;
Zhao, Yanxia;
Han, Xinhua;
Pan, Yueyin;
Huang, Xiang;
Li, Wei;
Wang, Kun;
Yin, Yongmei

Publication type:

Article

The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis.

Published in:

Cancers, 2021, v. 13, n. 9, p. 2005, doi. 10.3390/cancers13092005

By:

Erfani, Sonia;
Hua, Hui;
Pan, Yueyin;
Zhou, Binhua P.;
Yang, Xiuwei H.;
Cordes, Nils

Publication type:

Article

Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2009, v. 28, p. 1, doi. 10.1186/1756-9966-28-33

By:

Hongyang Wu;
Zhendong Chen;
Guoping Sun;
Kangsheng Gu;
Yueyin Pan;
Jiqing Hao;
Yingying Du;
Jie Ning

Publication type:

Article

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-820

By:

Xichun Hu;
Jun Cao;
Wenwei Hu;
Changping Wu;
Yueyin Pan;
Li Cai;
Zhongsheng Tong;
Shusen Wang;
Jin Li;
Zhonghua Wang;
Biyun Wang;
Xiaoyu Chen;
Hao Yu

Publication type:

Article

Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer.

Published in:

2014

By:

Hu, Xichun;
Cao, Jun;
Hu, Wenwei;
Wu, Changping;
Pan, Yueyin;
Cai, Li;
Tong, Zhongsheng;
Wang, Shusen;
Li, Jin;
Wang, Zhonghua;
Wang, Biyun;
Chen, Xiaoyu;
Yu, Hao

Publication type:

journal article